Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
CVS Health Corp (NY: CVS)
78.87 USD  +0.77 (+0.99%)
Streaming Delayed Price  /  Updated: 1:08 PM EDT, Sep 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,633,400
Open 78.04
Bid (Size) 78.87 (3)
Ask (Size) 78.88 (1)
Prev. Close 78.10
Today's Range 77.61 - 78.92
52wk Range 60.14 - 84.00
Shares Outstanding 1,016,646,347
Dividend Yield 2.54%
Performance
YTD
+7.28%
+7.28%
1 Month
+5.70%
+5.70%
3 Month
+16.43%
+16.43%
6 Month
+23.96%
+23.96%
1 Year
-5.33%
-5.33%
Top News
More News
CVS Health Earns IBD Rating Upgrade
CVS Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Read More
from Investor's Business Daily
CVS Health CEO Larry Merlo to Discuss Transformational Change in Health Care at Town Hall Los Angeles
Will Highlight the Company's Plan to Acquire Aetna as Key to Creating an Innovative, Community-Based Health Care Delivery Model Read More
from PR Newswire
More News
Read More
CVS Health Applauds FDA's Steps to Address the Epidemic of Youth Use of Electronic Cigarettes and Vaping Devices
from PR Newswire
CVS Health Helps Customers to prepare For Hurricane Florence
from PR Newswire
Teamsters Local 727 File New Unfair Labor Practice Charge Against CVS
from PR Newswire
UPDATE 4-Cigna deal gets antitrust nod, positive sign for CVS/Aetna
category companyNews
from Reuters: Company News
UPDATE 3-Cigna deal gets antitrust nod, positive sign for CVS/Aetna
category companyNews
from Reuters: Company News
IBD Rating Upgrades: CVS Health Shows Improved Price Strength
from Investor's Business Daily
UPDATE 2-Cigna-Express Scripts deal gets U.S. antitrust approval
category companyNews
from Reuters: Company News
U.S. review of CVS deal for Aetna may end soon -source
category companyNews
from Reuters: Company News
UPDATE 1-Cigna-Express Scripts deal gets U.S. antitrust approval
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.